Federal Panel Adds Fournier's Gangrene to Crowded Invokana MDL Court

Friday, August 2, 2019
Invokana Gangrene Amputation

In the latest Invokana lawsuit update, DrugNews has learned that a federal judicial panel has transferred new cases alleging a rare genital gangrene was caused by the popular diabetes drug Invokana to a special court that was already handling more than 1,000 claims for other side effects.

Multidistrict Litigation (MDL) court number 2750, located in the United States Federal District of New Jersey, is a special venue that was created in December 2016 to handle a growing number of lawsuits alleging side effects from Invokana.

At the time, these claims were limited to ketoacidosis and kidney damage. However, as the FDA uncovered new and unknown risks of the drug like lower limb amputations, the litigation grew to include other side effects.

At present, federal records show 1,190 people have now filed claims in the Invokana court for a variety of serious side effects.

The latest claims come after the FDA warned on August 29, 2018 that certain diabetes drugs in the SGLT2 class, like Invokana, Jardiance and Farxiga, might be associated with a rare gangrene of the genital area called Fournier’s Gangrene.

Fournier’s gangrene can spread quickly if not diagnosed and treated early, and can result in painful surgeries, extended hospital stays, or even death.

On June 4, 2019, the Judicial Panel for Multidistrict Litigation transferred two cases alleging Fournier’s Gangrene from Invokana to the larger Invokana MDL court, saying that it will expedite litigation to keep all Invokana side effect lawsuits together.

Although the cases from Kentucky and New York were only the second and third ever to be moved to the main Invokana MDL court, experts predict thousands could follow as more victims learn of the connection between their medication and this terrible condition.

In Invokana settlement news, insiders have reported that Johnson & Johnson is attempting to reach settlements in many of the cases filed already. The company has reportedly paid compensation to hundreds of victims of ketoacidosis or amputations, and may next turn their attention to cases alleging Fournier’s Gangrene.

In addition, DrugNews previously reported that Invokana had also been linked to rare cases of bladder cancer or kidney cancer, with lawyers also investigating claims against the manufacturer for these victims.

Follow DrugNews for the latest Invokana settlement updates, as well as breaking news on FDA warnings, drug safety studies and litigation.

For more information, or to speak directly with an attorney about your experience with a defective drug, contact us today.

 

Sources:

JPML. Transfer Order. (June 4, 2019). Retrieved from www.jpml.uscourts.gov

Invokana
Claim?
Fournier's Gangrene
Side Effects

Other drugs and devices in the news:

Friday, August 9, 2019
Surgical Stapler
Did Surgical Staple Companies Hide Thousands of Injuries?

This past spring, the FDA issued a warning affecting the millions of patients each year that undergo routine gastrointestinal, gynecologic...

Thursday, May 16, 2019
Uloric
Serious Health Warnings Added to Gout Drug Uloric

For the second time in just over a year, the FDA has added serious health warnings for patients that may be prescribed the gout medication Uloric, also known by its generic name febuxostat.

Get in touch with us.

Call, email or live chat with us today to see how we can help.

call DrugNews.net
Need a quick answer? Call us!
email DrugNews.net
Reach out to us by email.
live chat with DrugNews
We are here to help now